alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
• 

• REF ID:A67826 • ( 

1.'J 

• 

U8AIIllll FOR: &eflMl'ch and Denlo,.eat Dlrl111oa 

(TBIUt lar Plans It !raia1nc D1:'1M.oa) 

1.. In ~lDD with the tabulat1111 achlnnT now emp191ed 

ly tile SI.pal Iateollt t11\0tt 3ect!.on, thr: udereign.114 haw 1n'nn\e4 

a - and uef'ul dniM •h1cb aa7 be att&cbed to th• eleovtcal 

OOG9'1.ng 80l"ter ~ wblch •1ll b& or illportanae in t.:rt... -.1.- _. ot thl• aacb1• ill eode ooap11atioa u4 la other won .n 

relllt.ai1 thereto, ot a INN17 OOIVl8l"c1at cbal"aa\ar. 

L !la• pl'iaAlpal obJen ot t11e .lawmUoa ls to tra.nd'ona th• 

ei.~....- lato a dnioe ot exactl.1 op;>esite !uuct1oa. "f'l.a., 

to ._801't•, •...-..bte•, or diaarrbi• 1n a wllolq rand~ a8Q'MD&• 

a •t ot pmahe4 .arid• or1c1nall.J IUTIUleed 1n a dettalte • nplar 

119qaenae. Aaotller o'b3 eot lo to praTid.e a 1188.118 aml dedoe !or 

obtaialDL a wbolq :randoa, amul.l eupl• troa 11 larae set oi. pached 

OllJ'da. 

l• Ia Yi• ot tile tut tlaat aaob a 4erice will be 'fiery uetul 

1n code pNduction, 1t ls desir-.ble that pa.tiDnt ~t.P.VllC'atioD be aade 

1a order to protwt the ~·., int.rest~. 

4. .It the ••~ tiab, 1n Ylaw of the 11MhlM•• of the drrice 

t. oenala o...ra1&1 t.alulatJas iaaW.l&U.U .la whlch rama. 

..i.cuou ot pwlaed earcl• wt waatonal 17 i. .a, pel'lli•a10J1 

i• ftel••ted \o enter lato M10UatJ.ou •1th the Intenaat1onal ••w• lulltnea Corporation or &.-er OGll,pUiea, w1 th a Yi• to 

poald.llle Ml• of Cl0•••1al ri1ll~• to thle .lnftatloe. 

'· Attaehed hereto le a ~ ud deear1pt1on of the inYen- "1•, la tu tora or a ~ tntt. ot specit1cat1ou. 

, 

a. ·' 4 c 

!Declassified and approved for release by NSA on 09-05-2013 pursuant to E. 0. 1352§ 

...... .. • 4
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               MAR-31-1998
<CASH>                                          50,276
<SECURITIES>                                         0
<RECEIVABLES>                                   88,031
<ALLOWANCES>                                     9,383
<INVENTORY>                                          0
<CURRENT-ASSETS>                               141,163
<PP&E>                                          41,379
<DEPRECIATION>                                  30,964
<TOTAL-ASSETS>                                 199,600
<CURRENT-LIABILITIES>                           75,734
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           327
<OTHER-SE>                                      94,916
<TOTAL-LIABILITY-AND-EQUITY>                   199,600
<SALES>                                         55,863
<TOTAL-REVENUES>                                55,863
<CGS>                                           24,228
<TOTAL-COSTS>                                   24,228
<OTHER-EXPENSES>                                23,433
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  9,108
<INCOME-TAX>                                     3,718
<INCOME-CONTINUING>                              5,390
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     5,390
<EPS-PRIMARY>                                     0.18
<EPS-DILUTED>                                     0.17
        

</TABLE>
EXHIBIT 3.1.2


                            CERTIFICATE OF AMENDMENT
                                       OF
                          CERTIFICATE OF INCORPORATION
                                       OF
                           UNIGENE LABORATORIES, INC.




         UNIGENE LABORATORIES,  INC., a corporation organized and existing under
and by virtue of the  General  Corporation  Law of the State of  Delaware,  DOES
HEREBY CERTIFY:

         FIRST:  That the Board of Directors of Unigene  Laboratories,  Inc., by
the  unanimous  written  consent of its  members,  filed with the Minutes of the
Board,  duly  adopted  resolutions  setting  forth a proposed  Amendment  to the
Certificate of Incorporation of said Corporation, declaring said Amendment to be
advisable  and calling a meeting of the  stockholders  of said  Corporation  for
consideration thereof. The resolution setting forth the proposed Amendment is as
follows:

         RESOLVED,  that  the  Board of  Directors  hereby  declares  that it is
         advisable to increase  the number of shares of Common Stock  authorized
         for  issuance  by  amending   Article   FOURTH  of  the   Corporation's
         Certificate of Incorporation to read as follows:

                  "FOURTH:  The  total  number  of  shares  of stock  which  the
         Corporation   shall   have   authority   to  issue  is  sixty   million
         (60,000,000), having a par value of $.01 per share. All such shares are
         of one class and are common stock."

         SECOND:  That  thereafter,  pursuant  to  resolution  of its  Board  of
Directors,  an annual meeting of the  stockholders of said  Corporation was duly
called and held,  upon  notice in  accordance  with  Section  222 of the General
Corporation Law of the State of Delaware,  at which meeting the necessary number
of shares as required by statute were voted in favor of the Amendment.

        THIRD:  That said  Amendment  was duly  adopted in  accordance  with the
provisions  of  Section  242 of the  General  Corporation  Law of the  State  of
Delaware.


<PAGE>



         IN WITNESS  WHEREOF,  said Unigene  Laboratories,  Inc. has caused this
Certificate  to be signed by Warren P. Levy,  its  President,  and  attested  by
Ronald S. Levy, its Secretary, this 22nd day of August, 1997.



                                                      UNIGENE LABORATORIES, INC.


                                                      By: /s/ WARREN P. LEVY
                                                          ------------------
                                                          Warren P. Levy
                                                          President



ATTEST:


/s/RONALD S. LEVY
-----------------
Ronald S. Levy
Secretary
# C_2014366EN.01000101.xml

| 16.10.2014 | EN | Official Journal of the European Union | C 366/1 |
| --- | --- | --- | --- |

16.10.2014

EN

Official Journal of the European Union

C 366/1

---

Withdrawal of notification of a concentration

(Case M.7342 — Alcoa / Firth Rixson)

(Text with EEA relevance)

2014/C 366/01

(Council Regulation (EC) No 139/2004)

On 11 September 2014, the Commission received a notification of a proposed concentration between Alcoa Inc. (‘Alcoa’, United States) and Firth Rixson (United Kingdom). On 8 October 2014, the notifying party/ies informed the Commission that it/they withdrew its/their notification.

---
Exhibit 31.2





CERTIFICATION

I, Thomas J. Weldgen, Chief Financial Officer of CPAC, Inc., hereby certify that:
1.     I have reviewed this quarterly report on Form 10-Q of CPAC, Inc.
2.     Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
3.     Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
4.     The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
a)  designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
b)  evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this quarterly report based upon such evaluation; and
c)  disclosed in this quarterly report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.
5.     The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):
a)  all significant deficiencies in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)  any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



|Date: February 10, 2004 | /s/ Thomas J. Weldgen
Thomas J. Weldgen
Chief Financial Officer
|----------------------- | ---------------------------------------------------------------







---

25
|Exhibit 32. |  | Certification Pursuant to 18 U.S.C. Section 1350, As Adopted
|----------- |  | ------------------------------------------------------------

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002



In connection with the Quarterly Report of Southeastern Banking Corporation on Form 10-Q for the period ended September 30, 2003 as filed with the Securities and Exchange Commission on the date hereof (the Report),
we, Cornelius P. Holland, III, President & Chief Executive Officer of the Company, and Alyson G. Beasley, Vice President of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------

| | (2) | The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------------



/s/  CORNELIUS P. HOLLAND, IIICornelius P. Holland, III, President & CEO








/s/  ALYSON G. BEASLEYAlyson G. Beasley, Vice President




Date:November 14,
2003
EXHIBIT
32.1




CERTIFICATION
PURSUANT TO


18 U.S.C.
SECTION 1350


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES−OXLEY ACT OF 2002




In
connection with the Annual Report of Roomlinx, Inc. (the “Company”) on Form 10−K
for the year ended December 31, 2008 as filed with the Securities and Exchange
Commission on the date hereof (the “Report”), I, Michael S. Wasik, Chief
Executive Officer, hereby certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the SARBANES−OXLEY Act of 2002,
that:




1. The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and




2. The
information contained in the Report fairly presents, in all material respects,
the consolidated financial condition and consolidated results of operation of
the Company.


Date:
      3/30/09By:
              /s/
      Michael S. WasikMichael
      S. WasikChief
      Executive Officer and Chief Financial
Officer
SUPREME COURT OF THE STATE OF NEW YORK

Appellate Division, Fourth Judicial Department

901 

CA 15-02035 

PRESENT: CENTRA, J.P., PERADOTTO, DEJOSEPH, NEMOYER, AND CURRAN, JJ. 

 

LUCIA TERCILIO, PLAINTIFF-APPELLANT, 

V ORDER

FREDDY POLL-DELGADO, DEFENDANT-RESPONDENT. 

 

LAW OFFICES OF JOSE PEREZ, P.C., SYRACUSE (JOSE E. PEREZ OF COUNSEL), 

FOR PLAINTIFF-APPELLANT. 

BARTH SULLIVAN BEHR, BUFFALO (DANIEL K. CARTWRIGHT OF COUNSEL), FOR

DEFENDANT-RESPONDENT. 

 

Appeal from an order of the Supreme Court, Onondaga County

(Donald A. Greenwood, J.), entered July 23, 2015. The order granted

the motion of defendant for summary judgment dismissing the complaint

and denied the cross motion of plaintiff for partial summary judgment. 

It is hereby ORDERED that the order so appealed from is

unanimously affirmed without costs for reasons stated in the decision

at Supreme Court.

Entered: November 10, 2016 Frances E. Cafarell

Clerk of the Court
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-END>                               SEP-30-1995
<CASH>                                          11,796
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                 3,390
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                     69,831
<INVESTMENTS-CARRYING>                          23,382
<INVESTMENTS-MARKET>                            24,461
<LOANS>                                        164,906
<ALLOWANCE>                                      3,431
<TOTAL-ASSETS>                                 285,405
<DEPOSITS>                                     246,383
<SHORT-TERM>                                     2,758
<LIABILITIES-OTHER>                              3,612
<LONG-TERM>                                      3,025
<COMMON>                                         1,492
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                      28,135
<TOTAL-LIABILITIES-AND-EQUITY>                 285,405
<INTEREST-LOAN>                                 13,662
<INTEREST-INVEST>                                4,216
<INTEREST-OTHER>                                   416
<INTEREST-TOTAL>                                18,294
<INTEREST-DEPOSIT>                               7,161
<INTEREST-EXPENSE>                               7,419
<INTEREST-INCOME-NET>                           10,875
<LOAN-LOSSES>                                      900
<SECURITIES-GAINS>                                (41)
<EXPENSE-OTHER>                                  8,009
<INCOME-PRETAX>                                  4,498
<INCOME-PRE-EXTRAORDINARY>                       3,171
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     3,171
<EPS-PRIMARY>                                     2.66
<EPS-DILUTED>                                     2.66
<YIELD-ACTUAL>                                    5.87
<LOANS-NON>                                      1,274
<LOANS-PAST>                                     1,564
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                 3,257
<CHARGE-OFFS>                                    1,120
<RECOVERIES>                                       394
<ALLOWANCE-CLOSE>                                3,431
<ALLOWANCE-DOMESTIC>                             3,431
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        

</TABLE>
Exhibit 23

Consent of Independent Auditors


We consent to the incorporation by reference in the Registration Statements
(Form S-8 Nos. 33-66218 and 333-60643) pertaining to the 1992 Employee Incentive
Stock Option Plan, 1992 Stock Option Plan for Nonemployee Directors and 1993
Stock Option Plan of Funco, Inc. of our report dated May 10, 1999, with respect
to the consolidated financial statements and schedule of Funco, Inc. included in
this Annual Report (Form 10-K) for the year ended March 28, 1999.

/s/ Ernst & Young LLP

Minneapolis, Minnesota
June 23, 1999
II 

117TH CONGRESS 

1ST SESSION S. 21 

To extend the period of the temporary authority to extend contracts and 

leases under the ARMS Initiative. 

IN THE SENATE OF THE UNITED STATES 

JANUARY 22, 2021 

Ms. ERNST (for herself and Mr. GRASSLEY) introduced the following bill; 

which was read twice and referred to the Committee on Armed Services 

A BILL 

To extend the period of the temporary authority to extend 

contracts and leases under the ARMS Initiative. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. EXTENSION OF PERIOD OF TEMPORARY AU4 THORITY TO EXTEND CONTRACTS AND 

5 LEASES UNDER THE ARMS INITIATIVE. 

6 Section 343 of the National Defense Authorization 

7 Act for Fiscal Year 2016 (10 U.S.C. 7554 note) is amend8 ed by striking ‘‘the date that is five years after the date 


kjohnson on DSK79L0C42PROD with BILLS
2 

•S 21 IS

1 of the enactment of this Act’’ and inserting ‘‘November 

2 25, 2025,’’. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS
<TABLE>
EXHIBIT 11
                        

                      IGI, INC. AND SUBSIDIARIES
               COMPUTATION OF NET INCOME PER COMMON SHARE                                      (Unaudited)

(thousands, except per share information)
                   
                         Three months ended     Six months ended
                               June 30,             June 30,
                           1997      1996         1997    1996
                           ----      ----         ----    ----
<CAPTION>
<S>                       <C>       <C>          <C>     <C> 
Net income for primary
 earnings per share       $ 356     $  85        $ 718   $ 361

Weighed average shares
 outstanding              9,453     9,302        9,422   9,284
Common stock equivalents
(net ofcommon stock
 deemed reacquired)based
 on average market price     10       395           92     379
                          -----     -----        -----   -----
Total equivalent shares
 for primary computation  9,463     9,697        9,534   9,663
                          =====     =====        =====   =====

  

Per Share Amounts:
 Primary:
Net income                $ .04    $  .01        $ .08  $  .04 
                          =====    ======        =====  ======

         
Fully diluted earnings per share have been omitted as they approximate primary
earnings per share.

</TABLE>
# C_2015114EN.01000301.xml

| 9.4.2015 | EN | Official Journal of the European Union | C 114/3 |
| --- | --- | --- | --- |

9.4.2015

EN

Official Journal of the European Union

C 114/3

---

NOTICE OF OPEN COMPETITION

(2015/C 114/04)

The European Personnel Selection Office (EPSO) is organising the following open competition:

| | EPSO/AST/135/15 — Heads of Administration (AST 4) in EU Delegations |
| --- | --- |

EPSO/AST/135/15 — Heads of Administration (AST 4) in EU Delegations

The competition notice is published in 24 languages in
  Official Journal of the European Union C 114 A of 9 April 2015.

Official Journal of the European Union

Further information can be found on EPSO’s website: http://blogs.ec.europa.eu/eu-careers.info/

---
# C_2014412EN.01000101.xml

| 19.11.2014 | EN | Official Journal of the European Union | C 412/1 |
| --- | --- | --- | --- |

19.11.2014

EN

Official Journal of the European Union

C 412/1

---

Euro exchange rates (1)

1

18 November 2014

2014/C 412/01

1 euro =

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,2514 |
| JPY | Japanese yen | 145,91 |
| DKK | Danish krone | 7,4439 |
| GBP | Pound sterling | 0,79940 |
| SEK | Swedish krona | 9,2388 |
| CHF | Swiss franc | 1,2013 |
| ISK | Iceland króna | |
| NOK | Norwegian krone | 8,4290 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 27,677 |
| HUF | Hungarian forint | 305,54 |
| LTL | Lithuanian litas | 3,4528 |
| PLN | Polish zloty | 4,2141 |
| RON | Romanian leu | 4,4348 |
| TRY | Turkish lira | 2,7819 |
| AUD | Australian dollar | 1,4342 |
| CAD | Canadian dollar | 1,4130 |
| HKD | Hong Kong dollar | 9,7044 |
| NZD | New Zealand dollar | 1,5707 |
| SGD | Singapore dollar | 1,6240 |
| KRW | South Korean won | 1 374,09 |
| ZAR | South African rand | 13,8083 |
| CNY | Chinese yuan renminbi | 7,6605 |
| HRK | Croatian kuna | 7,6733 |
| IDR | Indonesian rupiah | 15 158,81 |
| MYR | Malaysian ringgit | 4,1961 |
| PHP | Philippine peso | 56,298 |
| RUB | Russian rouble | 58,4910 |
| THB | Thai baht | 41,006 |
| BRL | Brazilian real | 3,2543 |
| MXN | Mexican peso | 16,9671 |
| INR | Indian rupee | 77,2750 |

Currency

Exchange rate

USD

US dollar

1,2514

JPY

Japanese yen

145,91

DKK

Danish krone

7,4439

GBP

Pound sterling

0,79940

SEK

Swedish krona

9,2388

CHF

Swiss franc

1,2013

ISK

Iceland króna

NOK

Norwegian krone

8,4290

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

27,677

HUF

Hungarian forint

305,54

LTL

Lithuanian litas

3,4528

PLN

Polish zloty

4,2141

RON

Romanian leu

4,4348

TRY

Turkish lira

2,7819

AUD

Australian dollar

1,4342

CAD

Canadian dollar

1,4130

HKD

Hong Kong dollar

9,7044

NZD

New Zealand dollar

1,5707

SGD

Singapore dollar

1,6240

KRW

South Korean won

1 374,09

ZAR

South African rand

13,8083

CNY

Chinese yuan renminbi

7,6605

HRK

Croatian kuna

7,6733

IDR

Indonesian rupiah

15 158,81

MYR

Malaysian ringgit

4,1961

PHP

Philippine peso

56,298

RUB

Russian rouble

58,4910

THB

Thai baht

41,006

BRL

Brazilian real

3,2543

MXN

Mexican peso

16,9671

INR

Indian rupee

77,2750

---

(1)  Source: reference exchange rate published by the ECB.

1

Source

---
null

2016-11-22

555.59784

eng - Argued: 2016-11-22. Docket number: 15-3841